Cognizant Technology Solutions Stock: Analyst Estimates & Ratings

Cognizant Technology Solutions Corp_ Plano, TX office-by JHVEPhoto via iStock

Cognizant Technology Solutions Corporation (CTSH), headquartered in Teaneck, New Jersey, is a professional services company that provides consulting and technology, and outsourcing services. With a market cap of $35.4 billion, the company focuses on technology strategy consulting, complex systems development, enterprise software package implementation and maintenance, data warehousing, and business intelligence.

Shares of this outsourcing and technology giant have underperformed the broader market over the past year. CTSH has declined 5.4% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 16.6%. In 2025, CTSH stock is down 6.7%, compared to the SPX’s 7.8% rise on a YTD basis. 

Narrowing the focus, CTSH’s underperformance is also apparent compared to the Vanguard Information Technology Index ETF (VGT). The exchange-traded fund has gained about 25.8% over the past year. However, the ETF’s 11% returns on a YTD basis outshine the stock’s single-digit losses over the same time frame.

www.barchart.com

On Jul. 30, CTSH shares closed down by 1.8% after reporting its Q2 results. Its adjusted EPS of $1.31 beat Wall Street's expectations of $1.26. The company’s revenue was $5.3 billion, exceeding Wall Street forecasts of $5.2 billion. The company expects full-year adjusted EPS to be in the range of $5.08 to $5.22, and anticipates revenue to be between $20.7 billion and $21.1 billion.

For the current fiscal year, ending in December, analysts expect CTSH’s EPS to grow 8.2% to $5.14 on a diluted basis. The company’s earnings surprise history is impressive. It beat the consensus estimate in each of the last four quarters.

Among the 23 analysts covering CTSH stock, the consensus is a “Moderate Buy.” That’s based on seven “Strong Buy” ratings, one “Moderate Buy,” and 15 “Holds.”

www.barchart.com

This configuration is more bullish than a month ago, with five analysts suggesting a “Strong Buy.”

On Jul. 31, Baird kept a “Neutral” rating on CTSH and raised the price target to $84, implying a potential upside of 17.1% from current levels.

The mean price target of $89.09 represents a 24.1% premium to CTSH’s current price levels. The Street-high price target of $103 suggests an ambitious upside potential of 43.5%.


On the date of publication, Neha Panjwani did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.